Document Classification

Section Type: RESULTS

Text: After 6 months of treatment, the sibutramine, orlistat, and metformin groups all showed significantly reduced b. m. i. (13. 57 %, 9. 06 % and 9. 90 % respectively) ; waist circumference (10. 43 %, 6. 64 %, and 8. 10 % respectively) ; fasting and postprandial blood glucose levels ; insulin resistance as assessed by the homeostasis model for assessment of insulin resistance (HOMA) (38. 63 %, 32. 73 % and 39. 28 %, respectively) ; levels of total cholesterol, low-density lipoprotein (LDLC) cholesterol, very low-density lipoprotein (VLDLC) cholesterol, triglyceride, lipoprotein (a), and apolipoprotein B ; uric acid level ; pulse rate ; and systolic and diastolic blood pressure.